Detalles de la búsqueda
1.
An Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the Treatment of Advanced and Recurrent Endometrial Cancer.
Oncologist
; 27(12): 1058-1066, 2022 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36124638
2.
Second-line treatments in advanced biliary tract cancer: systematic literature review of efficacy, effectiveness and safety.
Future Oncol
; 18(18): 2321-2338, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35387496
3.
Burden of illness of follicular lymphoma and marginal zone lymphoma.
Ann Hematol
; 98(1): 175-183, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30315345
4.
Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia.
Ann Hematol
; 98(12): 2749-2760, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31745601
5.
A note on the relationship between age and health-related quality of life assessment.
Qual Life Res
; 28(5): 1201-1205, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30523567
6.
Healthcare Resource Utilization and Costs Among Commercially Insured Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States.
J Health Econ Outcomes Res
; 10(2): 104-110, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37954059
7.
Treatment Patterns and Outcomes Among Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States.
J Health Econ Outcomes Res
; 10(2): 82-90, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37905183
8.
Association Between Intermediate End Points, Progression-free Survival, and Overall Survival in First-line Advanced or Recurrent Endometrial Cancer.
Clin Ther
; 45(10): 983-990, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37689551
9.
Clinical efficacy and safety of first-line treatments in patients with mantle cell lymphoma: A systematic literature review.
Crit Rev Oncol Hematol
; 158: 103212, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33383209
10.
Systematic Literature Review of Economic Evaluations, Costs/Resource Use, and Quality of Life in Patients with Mantle Cell Lymphoma.
Pharmacoecon Open
; 5(2): 175-186, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32996067
11.
Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews.
Pharmacoecon Open
; 4(4): 575-591, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32200522
12.
Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L.
J Patient Rep Outcomes
; 4(1): 22, 2020 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32219576
13.
Systematic literature review of the global burden of illness of mantle cell lymphoma.
Curr Med Res Opin
; 36(5): 843-852, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162977
14.
PHEDRA: using real-world data to analyze treatment patterns and ibrutinib effectiveness in hematological malignancies.
J Comp Eff Res
; 7(1): 29-38, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28766976
Resultados
1 -
14
de 14
1
Próxima >
>>